Myopia Profile

Together we can slow the progression of myopia.

[Myopia Profile @myopiaprofile]

The HOYA roadshow webinar on “Confidence through Evidence” was hosted in November 2023. Prof. Debbie Jones spoke about the challenges faced by suboptimal spectacle lens designs, and how to counteract this by considering and prioritising scientific rigor. https://t.co/RFQ0yqAy2M

[Myopia Profile @myopiaprofile]

We speak to research optometrists Professor Earl Smith, Marcella McParland and Jill Woods about the contrast theory and the CYPRESS clinical trial which explored the use of the SightGlass DOT spectacle lenses for myopia control. https://t.co/BImDOxhCO4

[Myopia Profile @myopiaprofile]

The Asia-Pacific Myopia Management Symposium (APMMS) 2023, powered by CooperVision, brought global experts on myopia together to discuss the many facets of myopia and its management at the individual and national levels. https://t.co/Gqs6LLdxqH

[Myopia Profile @myopiaprofile]

Previous studies have shown that dual focus soft contact lenses have little effect on a child’s binocular function. This study finds that accommodative lag is larger and visual reaction times slower with dual focus lens wear in young adults. https://t.co/Vc4ypnNz9g

[Myopia Profile @myopiaprofile]

This study found that 45% of young adult screen users reported moderate or severe visual fatigue, and some measures of accommodation were correlated with visual fatigue levels. https://t.co/sz2rJOCpLA

[Myopia Profile @myopiaprofile]

The BLINK2 study found that a small short-term change in accommodation response while wearing multifocal contact lenses for myopia control did not translate to long-term effects on children’s accommodative status over longer periods of wear. https://t.co/lBW9ccTm8j

[Myopia Profile @myopiaprofile]

This trial found that although low-dose atropine was well-tolerated by US children over 2-years, there was little evidence of reduced myopia progression or axial length growth vs a placebo drop. https://t.co/hxAhQdfDf3

[Myopia Profile @myopiaprofile]

Myopia management is multifaceted and has an array of treatment options: corneal topography is an useful tool in guiding our direction not only when it comes to selecting a treatment option, but also diagnostically with regard to the ocular surface. https://t.co/iwhQ7P4lpr

[Myopia Profile @myopiaprofile]

Dr. Monica Jong is the Global Director of Professional Education, Myopia at Johnson & Johnson Medtech, and has played a pivotal role in the paradigm shift from myopia as a mere refractive error to a complex condition of epidemiological significance. https://t.co/1cThK0HNJd

[Myopia Profile @myopiaprofile]

The Childhood Atropine for Myopia Progression (CHAMP) trial is a randomized controlled trial that aimed to investigate the efficacy and safety profile of NVK002 0.01% and 0.02% atropine. https://t.co/RRzHF3s0tf

[Myopia Profile @myopiaprofile]

NVK002 is a new preparation of atropine that undergoes a commercial manufacturing process instead. In this Q&A, we talk to Dr. Houman Hemmati and Dr Kumaresh Soppimath about how NVK002 is different from traditional atropine formulations. https://t.co/rLLv7Zatro

[Myopia Profile @myopiaprofile]

The CHAMP randomized clinical trial found preservative-free 0.01% atropine could slow refractive error and axial length progression compared to placebo while providing minimal side-effects. https://t.co/spDtfTginf

[Myopia Profile @myopiaprofile]

Watch the co-authors Paul Chamberlain and Arthur Bradley discuss the results of the 'Six-Year Cumulative Treatment Effect and Treatment Efficacy of a Dual Focus Myopia Control Contact Lens' with Kate and Paul Gifford. https://t.co/W2wGwqQFZO

[Myopia Profile @myopiaprofile]

The ZEISS MyoCare technology is one of the latest in myopia management spectacle lens technology, and is currently available in many countries. We talk to Professor Padmaja Sankaridurg about the ZEISS MyoCare lenses and the research behind them. https://t.co/tMWVvDVsQB

[Myopia Profile @myopiaprofile]

The American Academy of Optometry (AAO) 2023 annual conference ran from October 11-14 in New Orleans. The conference brought together eye care practitioners and researchers from North America and around the world to share clinical and scientific insights. https://t.co/D8xFCCNykT

[Myopia Profile @myopiaprofile]

IT'S MYOPIA ACTION MONTH WEEK 3
The third chapter in the Myopia Action Month Online Seminar Series goes live on Tuesday September 19 at 2:00pm US CDT / 8:00pm BST / 9:00pm CEST.

[Myopia Profile @myopiaprofile]

MYOPIA ACTION MONTH: WEEK 2 BEGINS!

👀 To watch the Week 2 Online Seminar, go to https://t.co/0cpKVO4J9G and follow the links to enrol, access the recording, and check the schedule for the rest of the month. You can also access the recording from Week 1.

[Myopia Profile @myopiaprofile]

Myopia Action Month Online Seminar Series, Week 1 - don't miss it! This is coming to you streamed on Wed September 6, at 7:30 to 9:00pm US CDT time. When you register you'll be able to see the scheduled start time in your own time zone. Check it out via https://t.co/0cpKVO4J9G.

[Myopia Profile @myopiaprofile]

In this interview, we chatted with Professor Dominique Bremond-Gignac about her experiences of combination treatment; in particular, with prescribing HOYA MiYOSMART spectacle lenses and atropine for children with myopia. https://t.co/eiA2jylnt0

[Myopia Profile @myopiaprofile]

We talk to Dr May Zhang and Jeff Brown, leaders at HOYA Vision Care, about the importance of outdoor time and sun protection when it comes to managing children with myopia progression and how we can incorporate this into our clinical practice. https://t.co/MevflIXuwF